Andere talen Ascendis Pharma A/S

Aandelen

ASND

US04351P1012

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 25-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
136,9 ^USD	-4,37%		-2,81%	+8,72%

25/04	Europese aandelen verhandeld in de VS als American Depositary Receipts bewegen bescheiden hoger in de donderdaghandel	MT
24/04	Ascendis Pharma krijgt goedkeuring van Britse regelgevende instantie voor Yorvipath om hypoparathyreoïdie te behandelen	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024	25/04
European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	25/04
Ascendis Pharma - United Kingdom's MHRA Approves YORVIPATH in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism	25/04
Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism	24/04
United Kingdom’s MHRA Approves YORVIPATH® (palopegteriparatide) in Great Britain for the Treatment of Adults with Chronic Hypoparathyroidism	24/04
European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down	19/04
European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading	18/04
Ascendis Pharma A/S : Form 6-K	10/04
European Equities Traded in the US as American Depositary Receipts Slightly Higher Thursday	28/03
Ascendis Pharma A/S : Form 6-K	27/03
European Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading	21/03
Ascendis Pharma A/S : Form 6-K	14/03
European Equities Traded in the US as American Depositary Receipts Nudge Lower in Wednesday Trading	13/03
European Equities Traded in the US as American Depositary Receipts Trend Higher in Tuesday Trading	12/03
Ascendis Pharma to Participate in the Leerink Partners Global Biopharma Conference 2024	04/03
Ascendis Pharma A/S Appoints Mads Bodenhoff as Senior Vice President, Finance Principal Accounting Officer	29/02
European Equities Traded in the US as American Depositary Receipts Set to End Week Higher in Friday Trading	16/02
European Equities Traded in US as American Depositary Receipts Move Slightly Higher in Friday Trading	09/02
Ascendis Pharma Q4 Net Loss Narrows, Revenue Rises	07/02
Earnings Flash (ASND) ASCENDIS PHARMA Posts Q4 Revenue EUR137.7M	07/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Ascendis Pharma A/S

Aandelen

ASND

US04351P1012

Andere talen

Filters